1.
Girish Vasudeorao Kumthekar and Rajasekara Chakravarthi Madarasu. Utility of Testing Fibroblast Growth Factor 23 in Patients with Chronic Kidney Disease: A Single Center Experience. IDMMR-V7 [Internet]. 2022 Feb. 12 [cited 2026 Jun. 4];:119-27. Available from: https://stm.bookpi.org/IDMMR-V7/article/view/5770